Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults: A Randomized Crossover Proof-of-Concept Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Incremental Area Under the Curve for Postprandial Glucose
研究概览
简要总结
This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.
详细描述
This study investigated whether walking with a wearable hip exoskeleton could modulate postprandial glycemic and physiological responses in healthy adults. Using a randomized crossover design, each participant completed four experimental conditions in a controlled laboratory setting: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.
Postprandial glucose responses were assessed after meal ingestion during each experimental trial. Physiological responses, including heart rate, perceived exertion, and energy expenditure, were also evaluated to compare the metabolic and perceptual demands of walking with and without the wearable hip exoskeleton. The study was designed as a proof-of-concept trial to examine whether wearable hip exoskeleton-assisted walking may influence postprandial glucose regulation in healthy adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adults aged 20 to 65 years.
- •Participants who were able to complete walking trials with and without the wearable hip exoskeleton.
- •Participants who provided written informed consent before participation.
排除标准
- •Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders.
- •Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton.
- •Participants taking medications known to affect glucose metabolism.
- •Participants who were unable to comply with the study procedures.
结局指标
主要结局
Incremental Area Under the Curve for Postprandial Glucose
时间窗: Up to 120 minutes after meal ingestion during each experimental trial
Incremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.
次要结局
- Peak Postprandial Glucose Concentration(Up to 120 minutes after meal ingestion during each experimental trial)
- Heart Rate Response(From the start to the end of the 30-minute intervention or control period on each experimental trial day)
- Rating of Perceived Exertion(Immediately after each experimental condition)